rendering of a globe and news stories

PPD in the News

CenterWatch (May 2017)

Movement for real-world evidence as PPD and Evidera launch new research unit

CenterWatch reports on the combining of PPD’s medical affairs operations team and Evidera.

centerwatch logo
Outsourcing-Pharma (May 2017)

Acurian: new consulting service provides ‘continuum of support’

Outsourcing-Pharma reports on the introduction of Acurian Consulting Services.

Outsourcing Pharma Logo
Outsourcing-Pharma (May 2017)

PPD expands Virginia vaccine lab with an eye on assays

A report on the expansion of the PPD® Laboratories vaccine sciences lab in Richmond, Virginia, as reported in Outsourcing-Pharma.

Outsourcing Pharma Logo
Outsourcing-Pharma (April 2017)

PPD valued at more than $9bn as investors recapitalize

Outsourcing-Pharma provides insight into PPD's recapitalization.

Outsourcing Pharma Logo
FierceBiotech (April 2017)

Singapore, UAE government funds’ new investments put PPD at $9B

PPD’s recapitalization covered in FierceBiotech.

fierce biotech logo
FierceBiotech (March 2017)

PPD builds clinical research associates apprentice program, targets military veterans

FierceBiotech reports on PPD’s new, industry-first CRA apprentice program that focuses on military veterans.

fierce biotech logo
Regulatory Rapporteur (February 2017)

An analysis of specific Phase I safety issues

Kirsten Messmer co-authored this article that focuses on the importance of maximizing safety in clinical trials.

regulatory rapporteur logo
BioPharm International (February 2017)

Mass Spectrometry Measures Up to Analytical Challenges

Jie Ding discusses the importance of mass spectrometry in assigning the primary structure of biologic drugs.

biopharm logo
CenterWatch (February 2017)

The need for—and barriers to—adopting eSource

John Manns discusses the use of electronic approaches at clinical trial sites.

centerwatch logo